Expression of Shh/Gli1 in papillary thyroid carcinoma and its clinical biological significance
10.3760/cma.j.issn.1673-4203.2011.02.003
- VernacularTitle:甲状腺乳头状癌组织中Shh和Gli1的表达及其临床意义研究
- Author:
Xuehai BIAN
;
Guang ZHANG
;
Chunhai ZHANG
;
Daqi ZHANG
;
Le ZHOU
;
Hui SUN
- Publication Type:Journal Article
- Keywords:
Papillary thyroid carcinoma;
Shh;
Gli1;
Immunohistochemistry
- From:
International Journal of Surgery
2011;38(2):78-81
- CountryChina
- Language:Chinese
-
Abstract:
Objective To define the expression of Shh/Gli1,the key elements of Hedgehog signaling pathway in papillary thyroid carcinoma(PTC) and to explore the relationship between the expression of Shh/Gli1 and clinical significance.Methods The expression of Shh and Gli1 was examined in 142 cases of PTC tissues and adjacent tumor thyroid tissues as control by immunohistochemistry.The relationship between the expression of Shh/Gli1 and clinical characteristics of PTC patients was analyzed.Results The positive rate of the cytoplasm Shh expression and the nuclear Gli1 expression was 64.1% and 47.9% ,respectively.Significant difference was found between normal thyroid tissues and PTC.The research showed that the expression of Shh/Gli1 was related to the tumor size,clinical stages and lymph node metastasis,Shh was more significantly related to the tumor size(P ＜0.01) and Gli1 was more significantly related to the lymph node metastasis (P ＜ 0.01).Conclusions Varying expression of the main ligand Shh and transcription factor Gli1 in Hedgehog signaling pathway was found in PTC.The expression of Shh/Gli1 was related to the tumor size,clinical stage and lymph node metastasis,indicating that the aberrant activation of Shh signaling pathway plays some roles in PTC.Shh/Gli1 may be indicators for prognosis and ideal targets for therapy against PTC.
